Condition: Hereditary Cancer Syndrome · Sponsor: Columbia University
The investigators hypothesize that preconception and pregnancy may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal care or preconception care. The goal is to evaluate the acceptability of hereditary cancer testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention
This description comes directly from the study's public registry record.
Jessica Giordano · 212-305-7250 · jlg2197@cumc.columbia.edu
Reena Vattakalam · 212-342-6895 · rmv2110@cumc.columbia.edu
Always discuss trial participation with your own doctor first.
| Columbia University Irving Medical Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07195071